Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE3B | Q13370 | 2/20 | 0.39 |
| ▸ | PDE3A | Q14432 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18858530 | 0.83 | PDE3B (0.44) | PDE3BPDE3AKDM4EUSP2HPGD | |
| SCHEMBL12844139 | 0.79 | PDE3B (0.32) | PDE3BPDE3A | |
| SCHEMBL30610258 | 0.74 | PDE3B (0.40) | PDE3BPDE3AKDM4EUSP2HPGD | |
| SCHEMBL1532455 | 0.74 | PDE3B (0.40) | PDE3BPDE3AKDM4EUSP2HPGD | |
| SCHEMBL13980103 | 0.74 | PDE3B (0.40) | PDE3BPDE3AKDM4EUSP2HPGD | |
| SCHEMBL30110738 | 0.74 | PDE3B (0.40) | PDE3BPDE3AKDM4EUSP2HPGD | |
| SCHEMBL2732228 | 0.74 | PIK3CG (0.31) | — | |
| SCHEMBL9661177 | 0.73 | LMNA (0.43) | KDM4E | |
| SCHEMBL11786386 | 0.73 | PDE3B (0.39) | PDE3BPDE3AKDM4EUSP2HPGD | |
| SCHEMBL10964015 | 0.73 | PDE3B (0.39) | PDE3BPDE3AKDM4EUSP2HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2654432-B1 | VOLATILE ORGANIC COMPOUNDS FROM BACTERIAL ANTAGONISTS FOR CONTROLLING MICROBIAL GROWTH | ROOMBIOTIC GMBH (AT) | 2017-02-08 | — | — | EP | claimed |
| EP-2654432-A2 | VOLATILE ORGANIC COMPOUNDS FROM BACTERIAL ANTAGONISTS FOR CONTROLLING MICROBIAL GROWTH | Research Center Pharmaceutical Engineering GmbH (AT) | 2013-10-30 | — | — | EP | claimed |
| WO-2012085255-A2 | VOLATILE ORGANIC COMPOUNDS FROM BACTERIAL ANTAGONISTS FOR CONTROLLING MICROBIAL GROWTH | RESEARCH CENTER PHARMACEUTICAL ENGINEERING GMBH (AT) | 2012-06-28 | — | — | WO | claimed |
| CN-115895940-B | Application of paenibacillus piri volatile secondary metabolite in agricultural production | 广西民族大学 | 2024-05-24 | — | — | CN | disclosed |
| US-20230357319-A1 | PROTEASOME INHIBITORS | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION | 2023-11-09 | — | — | US | disclosed |
| CN-115895940-A | Application of paenibacillus dermorhinus volatile secondary metabolite in agricultural production | 广西民族大学 | 2023-04-04 | — | — | CN | disclosed |
| EP-2654432-B1 | VOLATILE ORGANIC COMPOUNDS FROM BACTERIAL ANTAGONISTS FOR CONTROLLING MICROBIAL GROWTH | ROOMBIOTIC GMBH (AT) | 2017-02-08 | — | — | EP | disclosed |
| EP-2654432-A2 | VOLATILE ORGANIC COMPOUNDS FROM BACTERIAL ANTAGONISTS FOR CONTROLLING MICROBIAL GROWTH | Research Center Pharmaceutical Engineering GmbH (AT) | 2013-10-30 | — | — | EP | disclosed |
| WO-2012085255-A2 | VOLATILE ORGANIC COMPOUNDS FROM BACTERIAL ANTAGONISTS FOR CONTROLLING MICROBIAL GROWTH | RESEARCH CENTER PHARMACEUTICAL ENGINEERING GMBH (AT) | 2012-06-28 | — | — | WO | disclosed |
| CN-1285717-A | Flavorants from yeast extracts | MALRA FOOD CO (GB) | 2001-02-28 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230357319-A1 | PROTEASOME INHIBITORS | PSMG3, PSME1, PSMB1 | PDE3B 4426/4885PDE3A 4283/4885KDM4E 1867/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.